UPDATED Apr 25, 2024
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
CERE | US$42.12 | 0.5% | 48.4% | US$7.6b | US$44.78 | PB11.4x | E12.6% | n/a | ||
ALVO | US$13.54 | 1.0% | 45.7% | US$3.7b | US$16.50 | PS40.5x | E95.2% | n/a | ||
KROS | US$56.24 | 1.9% | 29.3% | US$2.0b | US$88.11 | PS13433.5x | E14.4% | n/a | ||
ALXO | US$16.87 | 4.0% | 202.3% | US$819.1m | US$20.17 | PB4.5x | E11.5% | n/a | ||
FREQ | US$14.98 | 5.9% | -87.5% | US$547.3m | n/a | PB14.9x | E-4.7% | n/a | ||
NAMS | US$21.80 | 1.6% | 55.7% | US$1.9b | US$33.42 | PS138.1x | E22.9% | n/a | ||
WVE | US$5.08 | 5.0% | 32.6% | US$621.2m | US$13.00 | PS5.5x | E5.5% | n/a | ||
PRAX | US$52.88 | 3.4% | 250.8% | US$875.5m | US$138.60 | PS357.8x | E44.5% | n/a | ||
FTRE | US$37.25 | 0.8% | n/a | US$3.3b | US$40.06 | PS1.1x | E46.6% | n/a | ||
IMVT | US$28.80 | 0.7% | 79.0% | US$4.2b | US$50.87 | PB6.2x | E46.7% | n/a | ||
TPTX | US$76.01 | 0.7% | 18.9% | US$3.8b | US$76.00 | PS3776x | E24.7% | n/a | ||
ARCT | US$27.93 | 3.2% | 4.8% | US$751.7m | US$67.89 | PS4.5x | E60.0% | n/a | ||
GYRE | US$16.33 | 1.7% | n/a | US$1.4b | n/a | PS12.3x | n/a | n/a | ||
VERA | US$39.95 | 1.1% | 530.1% | US$2.2b | US$55.80 | PB21.4x | E26.5% | n/a | ||
PTCT | US$25.49 | 1.1% | -51.6% | US$2.0b | US$29.17 | PS2.1x | E33.5% | n/a | ||
HRMY | US$29.23 | 1.3% | -7.7% | US$1.6b | US$41.50 | PE12.9x | E25.8% | n/a | ||
OLK | US$22.20 | 0.8% | 5.5% | US$2.8b | US$26.00 | PS16.3x | E61.0% | n/a | ||
QTTB | US$28.24 | 6.2% | n/a | US$336.9m | US$47.50 | PE-6.3x | E-7.6% | n/a | ||
ISEE | US$39.95 | 0.4% | 236.3% | US$5.5b | US$40.00 | PB11.6x | E59.0% | n/a | ||
LGND | US$71.00 | 1.6% | -8.5% | US$1.2b | US$116.80 | PE23.4x | E-4.3% | n/a | ||
TWST | US$31.08 | 1.1% | 151.1% | US$1.8b | US$40.25 | PS6.8x | E19.3% | n/a | ||
AGEN | US$8.30 | 11.9% | -72.3% | US$155.4m | US$88.75 | PS1.1x | E9.1% | n/a | ||
SUPN | US$30.26 | 1.0% | -17.7% | US$1.6b | US$40.33 | PE1258.6x | E58.3% | n/a | ||
AXSM | US$71.52 | 0.5% | 0.5% | US$3.4b | US$121.13 | PS12.5x | E60.0% | n/a |